Trial intelligence / Profile preview

Effect of Adelmidrol Nasal Spray on Chronic Rhinosinusitis With Nasal Polyps

NCT07675512Completed

Sponsor
University of Campania Luigi Vanvitelli
Start
Jan 2025
Primary completion
Aug 2025
Countries
1
01

Overview

Randomised trial of Adelmidrol in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoint: Nasal Polyp Score at 9 months. Started Jan 2025; status: completed.

02

Drugs

Adelmidrol
03

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)

Beyond the preview

Go deeper on NCT07675512.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07675512.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call